Lalistat 2
Lalistat 2 is an inhibitor of many lipases especially Lysosomal acid lipase (LAL, IC50 = 152 nM), which is a key enzyme that degrades neutral lipids at an acidic pH in lysosomes. Lalistat 2 is commonly used to investigate the cell-specific functions of LAL and LAL deficiency in vitro, as well as specifically measure LAL activity in human blood samples or cells [1][2][3].
Product Specifications
CAS Number
1234569-09-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Lipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/lalistat-2.html
Purity
99.87
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N1CCCCC1)OC2=NSN=C2N3CCCCC3
Molecular Formula
C13H20N4O2S
Molecular Weight
296.40
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
WDR16 (CFAP52) Human qPCR Primer Pair (NM_145054)
Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3242), CF640R conjugate, 0.1mg/mL
Perforin-1 (Pore Forming Protein) (Apoptosis Marker) (PRF1/2470), CF488A conjugate, 0.1mg/mL
